We are live on ! Find out more
BAM

Brave Asset Management Portfolio holdings

AUM $467M
1-Year Est. Return 33.05%
This Fund
S&P 500
This Quarter Est. Return
+2.69%
1 Year Est. Return
+33.05%
3 Year Est. Return
+76.26%
5 Year Est. Return
+83.39%
10 Year Est. Return
+335.31%
AUM
$315M
AUM Growth
-$96.8M
Cap. Flow
-$102M
Cap. Flow %
-32.31%
Top 10 Hldgs %
61.11%
Holding
184
New
14
Increased
18
Reduced
51
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 15.93%
2 Communication Services 11.87%
3 Financials 11.48%
4 Consumer Discretionary 4.28%
5 Industrials 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SQQQ icon
126
ProShares UltraPro Short QQQ
SQQQ
$1.7B
$218K 0.07%
1,400
+295
+27% +$49.2K
HYT icon
127
BlackRock Corporate High Yield Fund
HYT
$1.37B
$216K 0.07%
22,000
-2,000
-8% -$19.8K
FYBR
128
DELISTED
Frontier Communications
FYBR
$215K 0.07%
6,191
MS icon
129
Morgan Stanley
MS
$341B
$214K 0.07%
+1,700
New +$209K
LIN icon
130
Linde
LIN
$223B
$213K 0.07%
509
AFL icon
131
Aflac
AFL
$63.7B
$213K 0.07%
2,059
QCOM icon
132
Qualcomm
QCOM
$171B
$212K 0.07%
1,379
-100
-7% -$16.4K
XLE icon
133
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
$212K 0.07%
4,944
-102
-2% -$4.63K
BN icon
134
Brookfield
BN
$109B
$207K 0.07%
+5,400
New +$203K
LNG icon
135
Cheniere Energy
LNG
$53.9B
$204K 0.06%
+950
New +$193K
WHR icon
136
Whirlpool
WHR
$2.89B
$200K 0.06%
+1,750
New +$193K
M icon
137
Macy's
M
$6.89B
$191K 0.06%
11,300
B
138
Barrick Mining
B
$64B
$155K 0.05%
10,000
VTRS icon
139
Viatris
VTRS
$20.6B
$130K 0.04%
10,438
INTC icon
140
CALL
Intel
INTC
$509B
$100K 0.03%
5,000
CRSP icon
141
CALL
CRISPR Therapeutics
CRSP
$5.23B
$98.4K 0.03%
+2,500
New +$118K
NGD
142
DELISTED
New Gold Inc
NGD
$95.5K 0.03%
38,500
DLTH icon
143
Duluth Holdings
DLTH
$159M
$86.5K 0.03%
28,000
-1,000
-3% -$3.63K
XRX icon
144
Xerox
XRX
$424M
$86.3K 0.03%
10,235
+76
+0.7% +$701
RIG icon
145
Transocean
RIG
$5.78B
$86.3K 0.03%
23,000
SRFM icon
146
Surf Air Mobility
SRFM
$91.9M
$86.2K 0.03%
+16,000
New +$44.4K
RXRX icon
147
Recursion Pharmaceuticals
RXRX
$1.76B
$77.3K 0.02%
11,433
+1,433
+14% +$9.63K
MVST icon
148
Microvast
MVST
$288M
$70.4K 0.02%
34,000
-17,000
-33% -$12.6K
QS icon
149
QuantumScape Corp
QS
$3.5B
$68.5K 0.02%
13,200
DHF
150
BNY Mellon High Yield Strategies Fund
DHF
$174M
$64K 0.02%
25,100

Similar funds

Brave Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Brave Asset Management held 184 positions worth $315M, down 24% from $412M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Brave Asset Management withdrew a net $102M in Q4 2024, closing 19 positions and reducing 51 holdings. Its most notable exit was iShares Core US Aggregate Bond ETF, an estimated $71.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Communication Services and Financials.

Against the trend, Brave Asset Management opened a new position in Vanguard Short-Term Treasury ETF worth $427K.

  • Brave Asset Management's largest Q4 2024 buy was Vanguard Short-Term Treasury ETF: 7,343 shares worth $427K.
  • Brave Asset Management added most to Vanguard FTSE All-World ex-US ETF in Q4 2024, an estimated $728K increase.
  • Brave Asset Management's biggest Q4 2024 reduction was iShares Gold Trust, cutting an estimated $18.6M.
  • Brave Asset Management fully exited iShares Core US Aggregate Bond ETF in Q4 2024, selling an estimated $71.9M.
  • Brave Asset Management's ten largest holdings make up 61% of its $315M portfolio in Q4 2024.
  • Brave Asset Management opened 14 new positions and closed 19 in Q4 2024.
  • Brave Asset Management's portfolio value fell 24% quarter-over-quarter to $315M.

Based on Brave Asset Management's 13F filing for Q4 2024, filed 14 Jan 2025.